Академический Документы
Профессиональный Документы
Культура Документы
Findings
In market cap GSK stands at No 2 as compared to other comp. and Pfizer being the highest. The EBITDA of GSK is highest 11.53 bn. The EPS of the GSK is 2.7 The net income of GSK is highest 8.08 bn.
The GSK main strategy here is that they are more focusing on their R&D. They have grown to a large extent in only one field. i.e Respiratory areas. Due to increase competition from generic drugs company has suffered a huge decline in their sales. 20% of GSK turnover is from paxil,wellbutrin,advair,avandia,and augmentin.
Conclusion
They have to shift their focus to other products. They should use their market cap to get more funds. Invest in the R&D of there existing products.
THANK YOU